Nearly half of Biotechs bank on Big Pharma, says ICON survey.
According to a recent survey commissioned by Clinical Research Organization (CRO) Icon, 48% of biotech companies rely on partnerships with Big Pharma as a funding source. The challenging funding environment has encouraged